PlainRecalls
FDA Drug Moderate Class II Terminated

AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for: Onyx Pharmaceuticals, Inc., Thousand Oaks, CA 91320-1799, U.S.A., NDC 76075-102-01

Reported: December 28, 2016 Initiated: December 15, 2016 #D-0226-2017

Product Description

AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for: Onyx Pharmaceuticals, Inc., Thousand Oaks, CA 91320-1799, U.S.A., NDC 76075-102-01

Reason for Recall

Lack of Assurance of Sterility: Potential cracks in glass vials

Details

Recalling Firm
Amgen, Inc.
Units Affected
11,434 vials
Distribution
United States and Puerto Rico No foreign distribution.
Location
Thousand Oaks, CA

Frequently Asked Questions

What product was recalled?
AMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For Intravenous Administration Only, Rx Only, Manufactured for: Onyx Pharmaceuticals, Inc., Thousand Oaks, CA 91320-1799, U.S.A., NDC 76075-102-01. Recalled by Amgen, Inc.. Units affected: 11,434 vials.
Why was this product recalled?
Lack of Assurance of Sterility: Potential cracks in glass vials
Which agency issued this recall?
This recall was issued by the FDA Drug on December 28, 2016. Severity: Moderate. Recall number: D-0226-2017.